Stockholm, August 15, 2024 –Intervacc AB (publ) and the Karolinska Institute, KI, announce that they have extended their collaboration to develop a new generation of animal health vaccines using recombinant fusion ... Read more
Stockholm, July 31, 2024 - Intervacc AB (publ) announces that the reduction of share capital and nominal value, decided by the Annual General Meeting on May 15, 2024, has been registered by the Swedish Companies ... Read more
Intervacc AB (publ) has held its Annual General Meeting (”AGM”) on Wednesday 15 May 2024, at which the following resolutions were made.
Adoption of the income statement ... Read more
The Group in summary
Read moreThe shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Annual General Meeting (“AGM”) to be held on Wednesday 15 May 2024 at 1.00 p.m. at Cirio Advokatbyrå, ... Read more